{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T11:54:38Z","timestamp":1781610878295,"version":"3.54.5"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,6,16]]},"DOI":"10.7759\/cureus.110952","type":"journal-article","created":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T11:24:48Z","timestamp":1781609088000},"source":"Crossref","is-referenced-by-count":0,"title":["Urological Complications of Morbid Obesity and the Role of Bariatric Surgery and Glucagon-Like Peptide-1 Receptor Agonists in Their Management: A Systematic Review"],"prefix":"10.7759","author":[{"given":"Waqas","family":"Khalil","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khadija","family":"Bibi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tauheed","family":"Fareed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sajad","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaginkere","family":"Chiran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"Obesity and overweight. (2025). Accessed. 2026: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/obesity-and-overweight."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.5812\/numonthly-154345","article-title":"Efficacy of body weight reduction in improving overactive bladder symptoms in obese and overweight women: a systematic review","volume":"17","author":"Tala MR","year":"2024","unstructured":"Tala MR, Ficky F, Lubis DL, Mirsya Warli S. Efficacy of body weight reduction in improving overactive bladder symptoms in obese and overweight women: a systematic review. Nephro-Urol Mon. 2024, 17:e154345. 10.5812\/numonthly-154345","journal-title":"Nephro-Urol Mon"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1136\/flgastro-2025-103307","article-title":"Obesity management medications for the surgeon","author":"Harris M","year":"2026","unstructured":"Harris M, Mahdi S, Fairfield C, et al.. Obesity management medications for the surgeon. Frontline Gastroenterol. 2026, 1-12. 10.1136\/flgastro-2025-103307","journal-title":"Frontline Gastroenterol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2032183","article-title":"Once-weekly semaglutide in adults with overweight or obesity","volume":"384","author":"Wilding JP","year":"2021","unstructured":"Wilding JP, Batterham RL, Calanna S, et al.. Once-weekly semaglutide in adults with overweight or obesity. N Engl J Med. 2021, 384:989-1002. 10.1056\/NEJMoa2032183","journal-title":"N Engl J Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2206038","article-title":"Tirzepatide once weekly for the treatment of obesity","volume":"387","author":"Jastreboff AM","year":"2022","unstructured":"Jastreboff AM, Aronne LJ, Ahmad NN, et al.. Tirzepatide once weekly for the treatment of obesity. N Engl J Med. 2022, 387:205-16. 10.1056\/NEJMoa2206038","journal-title":"N Engl J Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/andr.70022","article-title":"Effects of glucagon-like peptide 1 receptor agonists on testicular dysfunction: a systematic review and meta-analysis","volume":"13","author":"Salvio G","year":"2025","unstructured":"Salvio G, Ciarloni A, Ambo N, Bordoni M, Perrone M, Rossi S, Balercia G. Effects of glucagon-like peptide 1 receptor agonists on testicular dysfunction: a systematic review and meta-analysis. Andrology. 2025, 13:2022-34. 10.1111\/andr.70022","journal-title":"Andrology"},{"key":"ref7","article-title":"Worsening cardiometabolic health: treatment of obesity\/GLP 1 RA PDE5 meds & reduction of all-cause mortality","author":"Miner MM","year":"2025","unstructured":"Miner MM. Worsening cardiometabolic health: treatment of obesity\/GLP 1 RA PDE5 meds & reduction of all-cause mortality. GRU. 2025,","journal-title":"GRU"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.i4919","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne JA","year":"2016","unstructured":"Sterne JA, Hern\u00e1n MA, Reeves BC, et al.. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ. 2016, 355:i4919. 10.1136\/bmj.i4919","journal-title":"BMJ"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1002\/nau.20635","article-title":"A systematic review of overweight and obesity as risk factors and targets for clinical intervention for urinary incontinence in women","volume":"27","author":"Hunskaar S","year":"2008","unstructured":"Hunskaar S. A systematic review of overweight and obesity as risk factors and targets for clinical intervention for urinary incontinence in women. Neurourol Urodyn. 2008, 27:749-57. 10.1002\/nau.20635","journal-title":"Neurourol Urodyn"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/s0895-4356(00)00232-8","article-title":"A community-based epidemiological survey of female urinary incontinence: the Norwegian EPINCONT study","volume":"53","author":"Hannestad YS","year":"2000","unstructured":"Hannestad YS, Rortveit G, Sandvik H, Hunskaar S. A community-based epidemiological survey of female urinary incontinence: the Norwegian EPINCONT study. J Clin Epidemiol. 2000, 53:1150-7. 10.1016\/s0895-4356(00)00232-8","journal-title":"J Clin Epidemiol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2015.2609","article-title":"Urinary incontinence before and after bariatric surgery","volume":"175","author":"Subak LL","year":"2015","unstructured":"Subak LL, King WC, Belle SH, et al.. Urinary incontinence before and after bariatric surgery. JAMA Intern Med. 2015, 175:1378-87. 10.1001\/jamainternmed.2015.2609","journal-title":"JAMA Intern Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s11695-015-1969-z","article-title":"The effect of bariatric surgery on urinary incontinence in women","volume":"26","author":"O'Boyle CJ","year":"2016","unstructured":"O'Boyle CJ, O'Sullivan OE, Shabana H, Boyce M, O'Reilly BA. The effect of bariatric surgery on urinary incontinence in women. Obes Surg. 2016, 26:1471-8. 10.1007\/s11695-015-1969-z","journal-title":"Obes Surg"},{"key":"ref13","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejogrb.2018.10.011","article-title":"The long-term effects of bariatric surgery on female urinary incontinence","volume":"231","author":"Anglim B","year":"2018","unstructured":"Anglim B, O'Boyle C, O'Boyle J, et al.. The long-term effects of bariatric surgery on female urinary incontinence. Eur J Obstet Gynecol Reprod Biol. 2018, 231:15-8.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2007-1972","article-title":"Hypothalamic-pituitary-testicular axis disruptions in older men are differentially linked to age and modifiable risk factors: the European Male Aging Study","volume":"93","author":"Wu FC","year":"2008","unstructured":"Wu FC, Tajar A, Pye SR, et al.. Hypothalamic-pituitary-testicular axis disruptions in older men are differentially linked to age and modifiable risk factors: the European Male Aging Study. J Clin Endocrinol Metab. 2008, 93:2737-45. 10.1210\/jc.2007-1972","journal-title":"J Clin Endocrinol Metab"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.12659\/MSM.948180","article-title":"Mechanisms of Leydig cell aging and obesity-related hypogonadism in men: a review","volume":"31","author":"Huang X","year":"2025","unstructured":"Huang X, Zhao H, Wu X, Liang Y, Guan Q, Luo D, Yu C. Mechanisms of Leydig cell aging and obesity-related hypogonadism in men: a review. Med Sci Monit. 2025, 31:e948180. 10.12659\/MSM.948180","journal-title":"Med Sci Monit"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1111\/bju.14829","article-title":"The impact of bariatric surgery on urinary incontinence: a systematic review and meta-analysis","volume":"124","author":"Lee Y","year":"2019","unstructured":"Lee Y, Yu J, Tikkinen KA, et al.. The impact of bariatric surgery on urinary incontinence: a systematic review and meta-analysis. BJU Int. 2019, 124:917-34. 10.1111\/bju.14829","journal-title":"BJU Int"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1007\/s11695-018-3557-5","article-title":"Impact of bariatric surgery on male sex hormones and sperm quality: a systematic review and meta-analysis","volume":"29","author":"Lee Y","year":"2019","unstructured":"Lee Y, Dang JT, Switzer N, Yu J, Tian C, Birch DW, Karmali S. Impact of bariatric surgery on male sex hormones and sperm quality: a systematic review and meta-analysis. Obes Surg. 2019, 29:334-46. 10.1007\/s11695-018-3557-5","journal-title":"Obes Surg"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.V991645","article-title":"Body size and risk of kidney stones","volume":"9","author":"Curhan GC","year":"1998","unstructured":"Curhan GC, Willett WC, Rimm EB, Speizer FE, Stampfer MJ. Body size and risk of kidney stones. J Am Soc Nephrol. 1998, 9:1645-52. 10.1681\/ASN.V991645","journal-title":"J Am Soc Nephrol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1001\/jama.293.4.455","article-title":"Obesity, weight gain, and the risk of kidney stones","volume":"293","author":"Taylor EN","year":"2005","unstructured":"Taylor EN, Stampfer MJ, Curhan GC. Obesity, weight gain, and the risk of kidney stones. JAMA. 2005, 293:455-62. 10.1001\/jama.293.4.455","journal-title":"JAMA"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2010.01.037","article-title":"The effect of restrictive bariatric surgery on urinary stone risk factors","volume":"76","author":"Semins MJ","year":"2010","unstructured":"Semins MJ, Asplin JR, Steele K, et al.. The effect of restrictive bariatric surgery on urinary stone risk factors. Urology. 2010, 76:826-9. 10.1016\/j.urology.2010.01.037","journal-title":"Urology"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.semnephrol.2008.01.009","article-title":"Nephrolithiasis after bariatric surgery for obesity","volume":"28","author":"Lieske JC","year":"2008","unstructured":"Lieske JC, Kumar R, Collazo-Clavell ML. Nephrolithiasis after bariatric surgery for obesity. Semin Nephrol. 2008, 28:163-73. 10.1016\/j.semnephrol.2008.01.009","journal-title":"Semin Nephrol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.surg.2010.11.015","article-title":"Fat malabsorption and increased intestinal oxalate absorption are common after Roux-en-Y gastric bypass surgery","volume":"149","author":"Kumar R","year":"2011","unstructured":"Kumar R, Lieske JC, Collazo-Clavell ML, et al.. Fat malabsorption and increased intestinal oxalate absorption are common after Roux-en-Y gastric bypass surgery. Surgery. 2011, 149:654-61. 10.1016\/j.surg.2010.11.015","journal-title":"Surgery"},{"key":"ref23","doi-asserted-by":"crossref","DOI":"10.1016\/j.soard.2014.03.026","article-title":"Kidney stone incidence and metabolic urinary changes after modern bariatric surgery: review of clinical studies, experimental models, and prevention strategies","volume":"10","author":"Canales BK","year":"2014","unstructured":"Canales BK, Hatch M. Kidney stone incidence and metabolic urinary changes after modern bariatric surgery: review of clinical studies, experimental models, and prevention strategies. Surg Obes Relat Dis. 2014, 10:734-42.","journal-title":"Surg Obes Relat Dis"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jamcollsurg.2008.01.015","article-title":"Roux-en-Y gastric bypass is associated with early increased risk factors for development of calcium oxalate nephrolithiasis","volume":"206","author":"Duffey BG","year":"2008","unstructured":"Duffey BG, Pedro RN, Makhlouf A, et al.. Roux-en-Y gastric bypass is associated with early increased risk factors for development of calcium oxalate nephrolithiasis. J Am Coll Surg. 2008, 206:1145-53. 10.1016\/j.jamcollsurg.2008.01.015","journal-title":"J Am Coll Surg"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.3390\/ph19010136","article-title":"Comparative safety of GLP-1 receptor agonists across gastrointestinal, renal and pancreatic systems","volume":"19","author":"Shokr H","year":"2026","unstructured":"Shokr H, Mekkawy M, Hindi A. Comparative safety of GLP-1 receptor agonists across gastrointestinal, renal and pancreatic systems. Pharmaceuticals (Basel). 2026, 19:136. 10.3390\/ph19010136","journal-title":"Pharmaceuticals (Basel)"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2025.118731","article-title":"Comparative safety and side effects of semaglutide and tirzepatide: implications for clinical decision-making in obesity management","volume":"193","author":"Fahim SA","year":"2025","unstructured":"Fahim SA, Attia YM, Messiha A, Nabawy AY, Refaat F, El-Maadawy WH. Comparative safety and side effects of semaglutide and tirzepatide: implications for clinical decision-making in obesity management. Biomed Pharmacother. 2025, 193:118731. 10.1016\/j.biopha.2025.118731","journal-title":"Biomed Pharmacother"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1038\/nrneph.2016.75","article-title":"Obesity-related glomerulopathy: clinical and pathologic characteristics and pathogenesis","volume":"12","author":"D'Agati VD","year":"2016","unstructured":"D'Agati VD, Chagnac A, de Vries AP, Levi M, Porrini E, Herman-Edelstein M, Praga M. Obesity-related glomerulopathy: clinical and pathologic characteristics and pathogenesis. Nat Rev Nephrol. 2016, 12:453-71. 10.1038\/nrneph.2016.75","journal-title":"Nat Rev Nephrol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.116.305697","article-title":"Obesity-induced hypertension: interaction of neurohumoral and renal mechanisms","volume":"116","author":"Hall JE","year":"2015","unstructured":"Hall JE, do Carmo JM, da Silva AA, Wang Z, Hall ME. Obesity-induced hypertension: interaction of neurohumoral and renal mechanisms. Circ Res. 2015, 116:991-1006. 10.1161\/CIRCRESAHA.116.305697","journal-title":"Circ Res"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2022.101725","article-title":"Gastric bypass versus best medical treatment for diabetic kidney disease: 5 years follow up of a single-centre open label randomised controlled trial","volume":"53","author":"Cohen RV","year":"2022","unstructured":"Cohen RV, Pereira TV, Aboud CM, et al.. Gastric bypass versus best medical treatment for diabetic kidney disease: 5 years follow up of a single-centre open label randomised controlled trial. EClinicalMedicine. 2022, 53:101725. 10.1016\/j.eclinm.2022.101725","journal-title":"EClinicalMedicine"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0000000000004851","article-title":"Bariatric surgery and risk of death in persons with chronic kidney disease","volume":"276","author":"Coleman KJ","year":"2022","unstructured":"Coleman KJ, Shu YH, Fischer H, et al.. Bariatric surgery and risk of death in persons with chronic kidney disease. Ann Surg. 2022, 276:e784-91. 10.1097\/SLA.0000000000004851","journal-title":"Ann Surg"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.02940608","article-title":"Oxalate nephropathy complicating Roux-en-Y gastric bypass: an underrecognized cause of irreversible renal failure","volume":"3","author":"Nasr SH","year":"2008","unstructured":"Nasr SH, D'Agati VD, Said SM, Stokes MB, Largoza MV, Radhakrishnan J, Markowitz GS. Oxalate nephropathy complicating Roux-en-Y gastric bypass: an underrecognized cause of irreversible renal failure. Clin J Am Soc Nephrol. 2008, 3:1676-83. 10.2215\/CJN.02940608","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.2337\/dc24-1773","article-title":"Tirzepatide associated with reduced albuminuria in participants with type 2 diabetes: pooled post hoc analysis from the randomized active- and placebo-controlled SURPASS-1-5 clinical trials","volume":"48","author":"Apperloo EM","year":"2025","unstructured":"Apperloo EM, Tuttle KR, Pavo I, et al.. Tirzepatide associated with reduced albuminuria in participants with type 2 diabetes: pooled post hoc analysis from the randomized active- and placebo-controlled SURPASS-1-5 clinical trials. Diabetes Care. 2025, 48:430-6. 10.2337\/dc24-1773","journal-title":"Diabetes Care"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2025cqzf6qh7","article-title":"GLP-1 receptor agonist use and kidney outcomes in patients with cancer and type 2 diabetes: real-world global matched cohort analysis","volume":"36","author":"Khan FA","year":"2025","unstructured":"Khan FA, Capriles GM, Singeltary B. GLP-1 receptor agonist use and kidney outcomes in patients with cancer and type 2 diabetes: real-world global matched cohort analysis. J Am Soc Nephrol. 2025, 36:10.1681\/ASN.2025cqzf6qh7","journal-title":"J Am Soc Nephrol"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-025-03893-3","article-title":"Macrovascular and microvascular outcomes of metabolic surgery versus GLP-1 receptor agonists in patients with diabetes and obesity","volume":"31","author":"Gasoyan H","year":"2025","unstructured":"Gasoyan H, Alavi MH, Zajichek A, et al.. Macrovascular and microvascular outcomes of metabolic surgery versus GLP-1 receptor agonists in patients with diabetes and obesity. Nat Med. 2025, 31:3341-9. 10.1038\/s41591-025-03893-3","journal-title":"Nat Med"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa021423","article-title":"Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults","volume":"348","author":"Calle EE","year":"2003","unstructured":"Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med. 2003, 348:1625-38. 10.1056\/NEJMoa021423","journal-title":"N Engl J Med"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13164169","article-title":"Obesity as a risk factor for prostate cancer mortality: a systematic review and dose-response meta-analysis of 280,199 patients","volume":"13","author":"Rivera-Izquierdo M","year":"2021","unstructured":"Rivera-Izquierdo M, P\u00e9rez de Rojas J, Mart\u00ednez-Ruiz V, P\u00e9rez-G\u00f3mez B, S\u00e1nchez MJ, Khan KS, Jim\u00e9nez-Mole\u00f3n JJ. Obesity as a risk factor for prostate cancer mortality: a systematic review and dose-response meta-analysis of 280,199 patients. Cancers (Basel). 2021, 13:4169. 10.3390\/cancers13164169","journal-title":"Cancers (Basel)"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2012.11.013","article-title":"Obesity and prostate cancer: weighing the evidence","volume":"63","author":"Allott EH","year":"2013","unstructured":"Allott EH, Masko EM, Freedland SJ. Obesity and prostate cancer: weighing the evidence. Eur Urol. 2013, 63:800-9. 10.1016\/j.eururo.2012.11.013","journal-title":"Eur Urol"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1007\/s11701-023-01627-6","article-title":"Robot-assisted partial nephrectomy in morbidly obese patients: a VCQI database study","volume":"17","author":"Sharma G","year":"2023","unstructured":"Sharma G, Singh G, Ahluwalia P, et al.. Robot-assisted partial nephrectomy in morbidly obese patients: a VCQI database study. J Robot Surg. 2023, 17:2141-7. 10.1007\/s11701-023-01627-6","journal-title":"J Robot Surg"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1007\/s11934-022-01119-4","article-title":"Changes in urine composition and risk of kidney stone disease following bariatric surgery: a systematic review over last 2 decades","volume":"23","author":"Gadiyar N","year":"2022","unstructured":"Gadiyar N, Geraghty RM, Premakumar Y, Somani BK. Changes in urine composition and risk of kidney stone disease following bariatric surgery: a systematic review over last 2 decades. Curr Urol Rep. 2022, 23:279-95. 10.1007\/s11934-022-01119-4","journal-title":"Curr Urol Rep"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1007\/s11701-025-02584-y","article-title":"Research on the spectrum of complications in robotic surgery for obese urologic patients: a 6-year retrospective study","volume":"19","author":"Kan Y","year":"2025","unstructured":"Kan Y, Tai S, Wang Z. Research on the spectrum of complications in robotic surgery for obese urologic patients: a 6-year retrospective study. J Robot Surg. 2025, 19:407. 10.1007\/s11701-025-02584-y","journal-title":"J Robot Surg"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1007\/s11701-026-03178-y","article-title":"Impact of obesity on peri-operative outcomes at robotic-assisted, laparoscopic and open partial nephrectomy using national inpatient sample data","volume":"20","author":"Faheem MS","year":"2026","unstructured":"Faheem MS, Shahabi M, Ayub A, et al.. Impact of obesity on peri-operative outcomes at robotic-assisted, laparoscopic and open partial nephrectomy using national inpatient sample data. J Robot Surg. 2026, 20:272. 10.1007\/s11701-026-03178-y","journal-title":"J Robot Surg"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/505369-urological-complications-of-morbid-obesity-and-the-role-of-bariatric-surgery-and-glucagon-like-peptide-1-receptor-agonists-in-their-management-a-systematic-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T11:24:52Z","timestamp":1781609092000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/505369-urological-complications-of-morbid-obesity-and-the-role-of-bariatric-surgery-and-glucagon-like-peptide-1-receptor-agonists-in-their-management-a-systematic-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,16]]},"references-count":41,"URL":"https:\/\/doi.org\/10.7759\/cureus.110952","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6,16]]}}}